Bivalirudin versus heparin and provisional GP IIb/IIIa inhibitors in patients treated for ST-segment elevation myocardial infarctions: Comparison of outcomes in a "real-world" setting.

about

Bivalirudin versus heparin and provisional GP IIb/IIIa inhibitors in patients treated for ST-segment elevation myocardial infarctions: Comparison of outcomes in a "real-world" setting.

Item

http://www.wikidata.org/entity/Q38736998

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Bivalirudin versus heparin and ...... mes in a "real-world" setting.

@en

type

Item

label

Bivalirudin versus heparin and ...... mes in a "real-world" setting.

@en

prefLabel

Bivalirudin versus heparin and ...... mes in a "real-world" setting.

@en

P1476

Bivalirudin versus heparin and ...... omes in a "real-world" setting

@en

P2093

Andreas Fach

http://www.w3.org/2001/XMLSchema#string

Daniela Garstka

http://www.w3.org/2001/XMLSchema#string

Eduard Fiehn

http://www.w3.org/2001/XMLSchema#string

Janina Stehmeier

http://www.w3.org/2001/XMLSchema#string

Johannes Schmucker

http://www.w3.org/2001/XMLSchema#string

Rainer Hambrecht

http://www.w3.org/2001/XMLSchema#string

Robert Zabrocki

http://www.w3.org/2001/XMLSchema#string

Tina Backhaus

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials

Bivalirudin during primary PCI in acute myocardial infarction

The Impact of Bleeding Avoidance Strategies on Hospital-Level Variation in Bleeding Rates Following Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry CathPCI Registry.

Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials.

Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.

Bivalirudin is superior to heparins alone with bailout GP IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction transported emergently for primary percutaneous coronary intervention: a pre-specified analysis from the EUROMA

Third universal definition of myocardial infarction.

Transradial access mitigates bleeding benefit offered by bivalirudin over heparin in patients undergoing percutaneous coronary intervention: Insights from meta-analysis of randomized and observational studies.

The comparative efficacy of bivalirudin is markedly attenuated by use of radial access: insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium.

P304

301-308

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JOIC.12397

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Harm Wienbergen

P577

2017-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28593631

http://www.w3.org/2001/XMLSchema#string

P921

Aat atak